Search for: "Eli Lilly & Co."
Results 481 - 500
of 1,009
Sort by Relevance
|
Sort by Date
4 Nov 2011, 4:34 am
Eli Lilly & Co v Human Genome Sciences Inc [2011] UKSC 51; [2011] WLR (D) 312 “Since the Technical Board of Appeal of the European Patent Office had adopted a consistent approach to patents for biological material, the English courts should follow the principles of law set out in its decisions. [read post]
3 Nov 2011, 6:51 am
Other pharma companies have cracked the billion-dollar threshold, including Eli Lilly & Co., which agreed to pay $1.4 billion over sales of its Zyprexa anti-psychotic medicine. [read post]
2 Nov 2011, 8:46 pm
Eli Lilly (UK Supreme Court, 2 Nov 2011) [Decision] Case No. [2011] UKSC 51. [read post]
2 Nov 2011, 5:40 am
Supreme Court Rainy Sky SA & Orsd v Kookmin Bank [2011] UKSC 50 (2 November 2011) Human Genome Sciences Inc v Eli Lilly and Company [2011] UKSC 51 (2 November 2011) Court of Appeal (Civil Division) MD (Angola) & Ors, R (on the application of) v Secretary of State for the Home Department & Anor [2011] EWCA Civ 1238 (01 November 2011) Mitu v London Borough of Camden [2011] EWCA civ 1249 (01 November 2011) Williams v University of Birmingham & Anor [2011] EWCA Civ 1242… [read post]
2 Nov 2011, 4:53 am
Meanwhile, the Respondent [Eli Lilly] brought parallel proceedings in the High Court for revocation of the Patent in the UK. [read post]
2 Nov 2011, 3:24 am
On appeal from: [2010] EWCA Civ 33. [read post]
31 Oct 2011, 3:42 am
A. v Kookmin Bank, heard 27 July 2011, and Human Genome Sciences Inc v Eli Lilly and Company, heard 18 – 21 July 2011. [read post]
28 Oct 2011, 7:00 am
Eli Lilly & Co., 2009 WL 5216930, at *12 (E.D.N.Y. [read post]
25 Oct 2011, 6:28 pm
Eli Lilly and Co withdrew its sepsis drug Xigris from all markets after the product, deemed a potential big seller when it was approved a decade ago, failed to improve survival in a clinical trial.Sepsis is a severe, often life-threatening illness caused by the immune system's over-aggressive response to infections -- releasing inflammatory proteins that cause shock and shut down multiple organs. [read post]
24 Oct 2011, 9:36 am
Eli Lilly and Co., No. 2008-1248 (Fed. [read post]
24 Oct 2011, 2:52 am
Human Genome Sciences Inc v Eli Lilly and Company, heard 18 July 2011. [read post]
24 Oct 2011, 2:52 am
Human Genome Sciences Inc v Eli Lilly and Company, heard 18 July 2011. [read post]
7 Oct 2011, 4:18 am
Eli Lilly and Co (Docket Report) Faruno – Furuno files new 337 complaint regarding Certain Navigation Products (ITC 337 Law Blog) (ITC 337 Update) FlashPoint Technology – ITC issues public version of ALJ Luckern Final Initial and Recommended Determinations in Certain Electronic Imaging Devices (337-TA-726) (ITC 337 Law Blog) HTC – ITC institutes investigation (337-TA-808) against Apple regarding Certain Electronic Devices With Communication Capabilities… [read post]
6 Oct 2011, 4:37 pm
Eli Lilly & Co., 598 F.3d 1336, 1351 (Fed. [read post]
1 Oct 2011, 12:40 pm
He tries to parse the abominal Seventh Circuit case Eli Lilly v. [read post]
28 Sep 2011, 2:00 am
Armitage’s, of Eli Lilly and Company, presentation entitled ”A New 102: Reform, Not Recodification”…. [read post]
28 Sep 2011, 2:00 am
Armitage’s, of Eli Lilly and Company, presentation entitled ”A New 102: Reform, Not Recodification”…. [read post]
28 Sep 2011, 1:56 am
Highlights this week included: US: CAFC: Patent exhaustion does not apply to genetically engineered seed: Monsanto Co. v. [read post]
22 Sep 2011, 3:39 am
” The story reports on payments by Eli Lilly and Co., down 46 percent since 2009; GlaxoSmithKline down 29 percent. [read post]
20 Sep 2011, 3:52 am
" The story reports on payments by Eli Lilly and Co., down 46 percent since 2009; GlaxoSmithKline down 29 percent. [read post]
